Compare $CLYM vs $STTK | Chartloom

Compare

$CLYM vs $STTK

Climb Bio Inc · Shattuck Labs Inc

CLYM

Climb Bio Inc

STTK

Shattuck Labs Inc

Compare $CLYM vs $STTK

Comparing Climb Bio Inc and Shattuck Labs Inc

CLYMClimb Bio Inc

STTKShattuck Labs Inc

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

STTKShattuck Labs Inc

Market cap

$540M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.6%

YTD performance

60.9%

52W performance

149.8%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLYM

STTK

Detailed metrics comparison

CLYM

Climb Bio Inc

STTK

Shattuck Labs Inc

Market Cap

CLYM$630M

STTK$540M

Enterprise Value

CLYM$586M

STTK$476M

Price

CLYM$11.00

STTK$5.97

P/E Ratio

CLYMN/A

STTKN/A

P/S Ratio

CLYM0.00x

STTK539.51x

EV/Sales

CLYM0.00x

STTK476.21x

EV/EBITDA

CLYM0.00x

STTK0.00x

P/B Ratio

CLYM2.62x

STTK3.20x

P/FCF Ratio

CLYMN/A

STTKN/A

EV/FCF

CLYM-11.04x

STTK-11.55x

PEG Ratio

CLYMN/A

STTKN/A

Forward P/E (NTM)

CLYMN/A

STTKN/A

Forward P/S (NTM)

CLYMN/A

STTKN/A

Revenue (TTM)

CLYM$0

STTK$1M

Revenue Growth (YoY)

CLYMN/A

STTK-66.6%

Forward Rev Growth

CLYM27.3%

STTK118.7%

Gross Margin (TTM)

CLYM0.0%

STTK0.0%

Operating Margin (TTM)

CLYM0.0%

STTK0.0%

EBITDA Margin (TTM)

CLYM0.0%

STTK-5212.2%

Net Margin (TTM)

CLYM0.0%

STTK-5256.8%

FCF Margin (TTM)

CLYMN/A

STTK-4124.0%

Net Income (TTM)

CLYM$-58M

STTK$-53M

FCF (TTM)

CLYM$-53M

STTK$-41M

EPS (TTM)

CLYM-$0.76

STTK-$0.41

ROE (TTM)

CLYM-3179.0%

STTK-4357.0%

ROA (TTM)

CLYM-3079.0%

STTK-4090.0%

ROIC (TTM)

CLYM-3179.0%

STTK-4357.0%

Cash

CLYM$44M

STTK$63M

Debt

CLYM$0

STTK$0

Net Cash/Debt

CLYM$44M

STTK$63M

Current Ratio (TTM)

CLYM31.45x

STTK27.59x

Quick Ratio (TTM)

CLYM30.86x

STTK26.94x

Debt/Equity (TTM)

CLYM0.00x

STTK0.00x

Debt/Assets (TTM)

CLYM0.0%

STTK0.0%

Interest Coverage (TTM)

CLYMN/A

STTKN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

STTK0.00x

Beta

CLYM-0.01

STTK0.98

52W Performance

CLYM511.1%

STTK149.8%

YTD Performance

CLYM193.3%

STTK60.9%

% from 52W High

CLYM-40.0%

STTK-28.3%

% from 52W Low

CLYM572.8%

STTK251.2%

Asset Turnover (TTM)

CLYM0.00x

STTK0.01x

FCF Yield (TTM)

CLYM-8.4%

STTK-7.6%

Earnings Yield (TTM)

CLYM-9.1%

STTK-9.7%

Dividend Yield (TTM)

CLYMN/A

STTKN/A

Rule of 40

CLYM0.0

STTK-4,190.6

EV/GP/RG

CLYMN/A

STTKN/A

Ticker research

View CLYM research View STTK research

Metric	CLYM Climb Bio Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$630M	$540M
Enterprise Value	$586M	$476M
Price	$11.00	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	539.51x
EV/Sales	0.00x	476.21x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-66.6%
Forward Rev Growth	27.3%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5212.2%
Net Margin (TTM)	0.0%	-5256.8%
FCF Margin (TTM)	N/A	-4124.0%
Net Income (TTM)	$-58M	$-53M
FCF (TTM)	$-53M	$-41M
EPS (TTM)	-$0.76	-$0.41
ROE (TTM)	-3179.0%	-4357.0%
ROA (TTM)	-3079.0%	-4090.0%
ROIC (TTM)	-3179.0%	-4357.0%
Financial Health
Cash	$44M	$63M
Debt	$0	$0
Net Cash/Debt	$44M	$63M
Current Ratio (TTM)	31.45x	27.59x
Quick Ratio (TTM)	30.86x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	0.98
52W Performance	511.1%	149.8%
YTD Performance	193.3%	60.9%
% from 52W High	-40.0%	-28.3%
% from 52W Low	572.8%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-8.4%	-7.6%
Earnings Yield (TTM)	-9.1%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View STTK research

Valuation

P/S Ratio

CLYM

0.00x

STTK

539.51x

EV/FCF

STTK

-11.55x

CLYM

-11.04x

Growth & revenue

Revenue Growth TTM

STTK

-66.6%

Forward Revenue Growth

STTK

118.7%

CLYM

27.3%

Profitability & performance

Gross Margin

CLYM

0.0%

STTK

0.0%

ROE

CLYM

-3179.0%

STTK

-4357.0%

FCF Yield %

STTK

-7.6%

CLYM

-8.4%

52-Week Performance

CLYM

511.1%

STTK

149.8%

Detailed metrics comparison

CLYM

Climb Bio Inc

STTK

Shattuck Labs Inc

Market Cap

CLYM$630M

STTK$540M

Enterprise Value

CLYM$586M

STTK$476M

Price

CLYM$11.00

STTK$5.97

P/E Ratio

CLYMN/A

STTKN/A

P/S Ratio

CLYM0.00x

STTK539.51x

EV/Sales

CLYM0.00x

STTK476.21x

EV/EBITDA

CLYM0.00x

STTK0.00x

P/B Ratio

CLYM2.62x

STTK3.20x

P/FCF Ratio

CLYMN/A

STTKN/A

EV/FCF

CLYM-11.04x

STTK-11.55x

PEG Ratio

CLYMN/A

STTKN/A

Forward P/E (NTM)

CLYMN/A

STTKN/A

Forward P/S (NTM)

CLYMN/A

STTKN/A

Revenue (TTM)

CLYM$0

STTK$1M

Revenue Growth (YoY)

CLYMN/A

STTK-66.6%

Forward Rev Growth

CLYM27.3%

STTK118.7%

Gross Margin (TTM)

CLYM0.0%

STTK0.0%

Operating Margin (TTM)

CLYM0.0%

STTK0.0%

EBITDA Margin (TTM)

CLYM0.0%

STTK-5212.2%

Net Margin (TTM)

CLYM0.0%

STTK-5256.8%

FCF Margin (TTM)

CLYMN/A

STTK-4124.0%

Net Income (TTM)

CLYM$-58M

STTK$-53M

FCF (TTM)

CLYM$-53M

STTK$-41M

EPS (TTM)

CLYM-$0.76

STTK-$0.41

ROE (TTM)

CLYM-3179.0%

STTK-4357.0%

ROA (TTM)

CLYM-3079.0%

STTK-4090.0%

ROIC (TTM)

CLYM-3179.0%

STTK-4357.0%

Cash

CLYM$44M

STTK$63M

Debt

CLYM$0

STTK$0

Net Cash/Debt

CLYM$44M

STTK$63M

Current Ratio (TTM)

CLYM31.45x

STTK27.59x

Quick Ratio (TTM)

CLYM30.86x

STTK26.94x

Debt/Equity (TTM)

CLYM0.00x

STTK0.00x

Debt/Assets (TTM)

CLYM0.0%

STTK0.0%

Interest Coverage (TTM)

CLYMN/A

STTKN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

STTK0.00x

Beta

CLYM-0.01

STTK0.98

52W Performance

CLYM511.1%

STTK149.8%

YTD Performance

CLYM193.3%

STTK60.9%

% from 52W High

CLYM-40.0%

STTK-28.3%

% from 52W Low

CLYM572.8%

STTK251.2%

Asset Turnover (TTM)

CLYM0.00x

STTK0.01x

FCF Yield (TTM)

CLYM-8.4%

STTK-7.6%

Earnings Yield (TTM)

CLYM-9.1%

STTK-9.7%

Dividend Yield (TTM)

CLYMN/A

STTKN/A

Rule of 40

CLYM0.0

STTK-4,190.6

EV/GP/RG

CLYMN/A

STTKN/A

Ticker research

View CLYM research View STTK research

Metric	CLYM Climb Bio Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$630M	$540M
Enterprise Value	$586M	$476M
Price	$11.00	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	539.51x
EV/Sales	0.00x	476.21x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-66.6%
Forward Rev Growth	27.3%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5212.2%
Net Margin (TTM)	0.0%	-5256.8%
FCF Margin (TTM)	N/A	-4124.0%
Net Income (TTM)	$-58M	$-53M
FCF (TTM)	$-53M	$-41M
EPS (TTM)	-$0.76	-$0.41
ROE (TTM)	-3179.0%	-4357.0%
ROA (TTM)	-3079.0%	-4090.0%
ROIC (TTM)	-3179.0%	-4357.0%
Financial Health
Cash	$44M	$63M
Debt	$0	$0
Net Cash/Debt	$44M	$63M
Current Ratio (TTM)	31.45x	27.59x
Quick Ratio (TTM)	30.86x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	0.98
52W Performance	511.1%	149.8%
YTD Performance	193.3%	60.9%
% from 52W High	-40.0%	-28.3%
% from 52W Low	572.8%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-8.4%	-7.6%
Earnings Yield (TTM)	-9.1%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View STTK research